JPRN-UMIN000005191招募中2 期
XELOX stop-and-go trial:A phase 2 study of 1st line chemotherapy for unresectable or recurrent colorectal cancer. - FMOG1001 XELOX stop and Go
Hematology and Oncology, Kyushu University Hospital0 个研究点目标入组 37 人开始时间: 2011年3月6日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 37
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Double cancer, severe allergic history, active infections, severe complications
研究者
相似试验
已完成
不适用
A exploratory phase II study of SOX followed by interval S-1 alone therapy for advanced gastric cancer: Stop and Go studyadvanced gastric cancerJPRN-UMIN000023527Department of Surgery, Gastroenterological Center, Medical Center, Yokohama City University24
已完成
2 期
Phase II clinical trial of the first-line Stop-and-Go modified FOLFOX6 and bevacizmab for patients with unresectable/recurrent colorectal cancercolorectal cancerJPRN-UMIN000001233Mlnlstry of health, Labour and Welfare50
尚未招募
2 期
Phase II Trial of Doxycycline with Radiotherapy for Rectal CancerRectal CancerCancer - Bowel - Back passage (rectum) or large bowel (colon)ACTRN12620000815965Dr Natalie Briggs40
进行中（未招募）
1 期
A trial of a new drug added to an existing approved treatment of patientswith advanced breast cancer of specific typeMedDRA version: 14.0Level: PTClassification code 10006187Term: Breast cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)Breast cancerEUCTR2010-020395-28-DKMERRIMACK PHARMACEUTICALS130
进行中（未招募）
不适用
A trial of a new drug added to an existing approved treatment of patients with advanced breast cancer of specific typeBreast cancerEUCTR2010-020395-28-DEMERRIMACK PHARMACEUTICALS130